Oyster Point Pharma Announces Appointment of George Eliades to Board of Directors
April 05, 2021 at 06:00 am EDT
Oyster Point Pharma, Inc. announced the appointment of an additional member to its Board of Directors. Effective immediately, George Eliades, Ph.D, current Senior Vice President, Corporate Development and Chief Transformation Officer of Jazz Pharmaceuticals, will join Oyster Point's Board of Directors and serve as a member of the Compensation Committee.